tradingkey.logo


tradingkey.logo


Labcorp Holdings Inc

LH
264.200USD
-4.180-1.56%
終倀 03/27, 16:00ET15分遅れの株䟡
25.65B時䟡総額
25.77盎近12ヶ月PER


Labcorp Holdings Inc

264.200
-4.180-1.56%

詳现情報 Labcorp Holdings Inc 䌁業名

Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.

Labcorp Holdings Incの䌁業情報


䌁業コヌドLH
䌚瀟名Labcorp Holdings Inc
䞊堎日Apr 24, 1991
最高経営責任者「CEO」Schechter (Adam H)
埓業員数70000
蚌刞皮類Ordinary Share
決算期末Apr 24
本瀟所圚地358 S Main St
郜垂BURLINGTON
蚌刞取匕所NASDAQ OMX NASDAQ Basic NYSE
囜United States of America
郵䟿番号27215
電話番号13362291127
りェブサむトhttps://www.labcorp.com/
䌁業コヌドLH
䞊堎日Apr 24, 1991
最高経営責任者「CEO」Schechter (Adam H)

Labcorp Holdings Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Adam H. Schechter
Mr. Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
80.77K
-10.78%
Dr. Brian J. Caveney, M.D., J.D.
Dr. Brian J. Caveney, M.D., J.D.
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
30.00K
-0.21%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Executive Vice President - Special Advisor, Strategy
Executive Vice President - Special Advisor, Strategy
22.53K
+8.75%
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Independent Director
Independent Director
13.78K
+6.51%
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Lead Independent Director
Lead Independent Director
13.74K
+6.53%
Ms. Kerrii B. Anderson, CPA
Ms. Kerrii B. Anderson, CPA
Independent Director
Independent Director
9.56K
+9.38%
Mr. Mark S. Schroeder
Mr. Mark S. Schroeder
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
6.47K
+23.37%
Ms. Amy B. Summy
Ms. Amy B. Summy
Executive Vice President, Chief Marketing Officer
Executive Vice President, Chief Marketing Officer
5.72K
+7.34%
Ms. Megan D. Bailey
Ms. Megan D. Bailey
Executive Vice President and President - Central Laboratories and International
Executive Vice President and President - Central Laboratories and International
4.15K
+13.36%
Ms. Kathryn E. Wengel
Ms. Kathryn E. Wengel
Independent Director
Independent Director
4.13K
+21.70%
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Adam H. Schechter
Mr. Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
80.77K
-10.78%
Dr. Brian J. Caveney, M.D., J.D.
Dr. Brian J. Caveney, M.D., J.D.
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
30.00K
-0.21%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Executive Vice President - Special Advisor, Strategy
Executive Vice President - Special Advisor, Strategy
22.53K
+8.75%
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Independent Director
Independent Director
13.78K
+6.51%
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Lead Independent Director
Lead Independent Director
13.74K
+6.53%
Ms. Kerrii B. Anderson, CPA
Ms. Kerrii B. Anderson, CPA
Independent Director
Independent Director
9.56K
+9.38%

収益内蚳

通貚: USD曎新時刻: Mar 12, 2025
通貚: USD曎新時刻: Mar 12, 2025
FY2021
FY2020
FY2019
䌚瀟から関連デヌタがただ開瀺されおいたせん。
地域別USD
䌚瀟名
収益
比率
Northern America
13.09B
81.22%
Europe
2.05B
12.72%
Other Countries
976.40M
6.06%
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Fri, Feb 20
曎新時刻: Fri, Feb 20
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
The Vanguard Group, Inc.
11.91%
Victory Capital Management Inc.
6.50%
BlackRock Institutional Trust Company, N.A.
5.37%
State Street Investment Management (US)
4.64%
Allspring Global Investments, LLC
2.68%
他の
68.90%
株䞻統蚈
株䞻統蚈
比率
The Vanguard Group, Inc.
11.91%
Victory Capital Management Inc.
6.50%
BlackRock Institutional Trust Company, N.A.
5.37%
State Street Investment Management (US)
4.64%
Allspring Global Investments, LLC
2.68%
他の
68.90%
皮類
株䞻統蚈
比率
Investment Advisor
50.07%
Investment Advisor/Hedge Fund
40.31%
Research Firm
2.55%
Hedge Fund
2.32%
Pension Fund
1.96%
Bank and Trust
1.57%
Sovereign Wealth Fund
1.25%
Family Office
0.51%
Individual Investor
0.38%

機関投資家保有株


曎新時刻: Thu, Jan 1
曎新時刻: Thu, Jan 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q4
1846
81.59M
98.42%
-4.50M
2025Q3
1802
83.09M
100.23%
+765.81K
2025Q2
1825
81.46M
98.03%
-5.42M
2025Q1
1872
81.69M
97.58%
-5.17M
2024Q4
1872
81.10M
96.90%
-5.32M
2024Q3
1856
80.09M
95.55%
-6.82M
2024Q2
1876
81.29M
96.43%
-7.49M
2024Q1
1904
82.39M
97.73%
-8.65M
2023Q4
1947
83.11M
99.02%
-9.76M
2023Q3
1930
84.34M
99.29%
-7.18M
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
The Vanguard Group, Inc.
9.78M
11.79%
-66.55K
-0.68%
Sep 30, 2025
Victory Capital Management Inc.
2.64M
3.18%
+440.22K
+20.04%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
4.39M
5.3%
-10.58K
-0.24%
Sep 30, 2025
State Street Investment Management (US)
3.83M
4.62%
-31.13K
-0.81%
Sep 30, 2025
Allspring Global Investments, LLC
2.00M
2.41%
-4.51K
-0.23%
Sep 30, 2025
Geode Capital Management, L.L.C.
2.12M
2.56%
+9.78K
+0.46%
Sep 30, 2025
Select Equity Group, L.P.
1.84M
2.22%
-295.76K
-13.87%
Sep 30, 2025
Wellington Management Company, LLP
2.11M
2.54%
+289.03K
+15.91%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
1.25M
1.5%
-41.66K
-3.23%
Sep 30, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
iShares U.S. Healthcare Providers ETF
3.32%
Knowledge Leaders Developed World ETF
2.73%
Thrivent Small-Mid Cap ESG ETF
2.26%
State Street SPDR S&P Health Care Services ETF
1.9%
Schwab Ariel Opportunities ETF
1.62%
Brandes US Value ETF
1.56%
Invesco S&P 500 Equal Weight Health Care ETF
1.52%
Madison Covered Call ETF
1.49%
Nuveen ESG Mid-Cap Value ETF
1.4%
Franklin Genomic Advancements ETF
1.25%
詳现を芋る
iShares U.S. Healthcare Providers ETF
比率3.32%
Knowledge Leaders Developed World ETF
比率2.73%
Thrivent Small-Mid Cap ESG ETF
比率2.26%
State Street SPDR S&P Health Care Services ETF
比率1.9%
Schwab Ariel Opportunities ETF
比率1.62%
Brandes US Value ETF
比率1.56%
Invesco S&P 500 Equal Weight Health Care ETF
比率1.52%
Madison Covered Call ETF
比率1.49%
Nuveen ESG Mid-Cap Value ETF
比率1.4%
Franklin Genomic Advancements ETF
比率1.25%

配圓金


過去5幎間の配圓金総支払額は 692.30M 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
Jan 14, 2026
LH.NB Final Cash Dividend of gross USD 0.72 paid on Mar 12, 2026 going ex on Feb 27, 2026
Feb 27, 2026
Mar 12, 2026
Feb 27, 2026
Oct 08, 2025
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Dec 11, 2025 going ex on Nov 26, 2025
Nov 26, 2025
Dec 11, 2025
Nov 26, 2025
Jul 10, 2025
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Sep 11, 2025 going ex on Aug 28, 2025
Aug 28, 2025
Sep 11, 2025
Aug 28, 2025
Apr 10, 2025
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Jun 11, 2025 going ex on May 29, 2025
May 29, 2025
Jun 11, 2025
May 29, 2025
Jan 09, 2025
LH.NB Final Cash Dividend of gross USD 0.72 paid on Mar 12, 2025 going ex on Feb 27, 2025
Feb 27, 2025
Mar 12, 2025
Feb 27, 2025
Oct 10, 2024
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Dec 13, 2024 going ex on Nov 26, 2024
Nov 26, 2024
Dec 13, 2024
Nov 26, 2024
Jul 25, 2024
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Sep 13, 2024 going ex on Aug 29, 2024
Aug 29, 2024
Sep 13, 2024
Aug 29, 2024
Apr 11, 2024
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Jun 12, 2024 going ex on May 24, 2024
May 28, 2024
Jun 12, 2024
May 24, 2024
Jan 12, 2024
LH.NB Final Cash Dividend of gross USD 0.72 paid on Mar 13, 2024 going ex on Feb 26, 2024
Feb 27, 2024
Mar 13, 2024
Feb 26, 2024
Oct 12, 2023
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Dec 12, 2023 going ex on Nov 07, 2023
Nov 08, 2023
Dec 12, 2023
Nov 07, 2023
詳现を芋る

株匏分割


日付
配圓萜ち日
皮類
比率
デヌタなし
日付
配圓萜ち日
皮類
比率
デヌタなし
KeyAI
î™